|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 38/18 | |||
| A61P 25/28 | |||
| A61P 27/06 | |||
| C12N 15/63 | |||
| C12N 15/861 |
| (11) | Number of the document | 3606546 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18715911.6 |
| Date of filing the European patent application | 2018-03-28 | |
| (97) | Date of publication of the European application | 2020-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2018/050824 |
| Date | 2018-03-28 |
| (87) | Number | WO 2018/185468 |
| Date | 2018-10-11 |
| (30) | Number | Date | Country code |
| 201705484 | 2017-04-05 | GB |
| (72) |
WIDDOWSON, Peter, GB
MARTIN, Keith, GB
|
| (73) |
Quethera Limited ,
300 Dashwood Lang Road
Bourne Business Park, Addlestone, KT15 2NX,
GB
|
| (54) | GENETIC CONSTRUCT FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDER OR STROKE |
| GENETIC CONSTRUCT FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDER OR STROKE |